Main Session
Sep 28
SS 03 - GU 1: Advances in Localized Prostate Cancer

119 - Conventional vs. Hypofractionated, Radiotherapy for High-Risk Prostate Cancer: 10-Year Outcomes of the Randomized, Non-Inferiority, Phase 3 PCS5 Trial

03:20pm - 03:30pm PT

Presenter(s)

Tamim Niazi, MD - McGill University, Montreal, QC